The systemic delivery of bleomycin (BLM) to mice through subcutaneously implanted osmotic minipumps may be used to experimentally mimic the typical features of systemic sclerosis and related interstitial lung diseases. The published studies on this model principally focused on induced dermal modifications, probably because lung lesions are typically mild, subpleurally localized and difficult to analyze. The use of high BLM doses to increase their severity has been proposed, but is ethically questionable because of compromising animal welfare. We propose a tailored histomorphometric method suitable to detect and quantify this type of mild lung lesions. Using a two steps automated image analysis, a peripheral region of interest with a depth of 250 µm from the pleural edge was defined on whole slide images and the fibrotic foci were histomorphometrically characterized. The effects of different BLM doses on lung alterations were evaluated in C57BL/6 mice and 60 U/kg resulted in a fair compromise between fibrotic lesions and animal welfare. This dose was also tested in time-course experiments. The analysis revealed a peak of histologic fibrotic-like alterations, cytokine expression, metalloprotease and macrophagic activation, between the 21th and 28th day post pump implant. The induced dermal fibrosis was characterized by the progressive loss of the white dermal adipose layer, an increase of dermal thickness, dermal hyperplasia and more compacted collagen fibers. Despite the trend to spontaneous resolution, our model allowed a double organ readout of the BLM effect and the identification of a therapeutic window for testing pharmacological compounds without using life threatening doses.

Modeling pulmonary fibrosis through Bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation / Ravanetti, Francesca; Ragionieri, Luisa; Ciccimarra, Roberta; Ruscitti, Francesca; Pompilio, Daniela; Gazza, Ferdinando; Villetti, Gino; Cacchioli, Antonio; Stellari, Fabio F.. - In: AMERICAN JOURNAL OF PHYSIOLOGY. LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. - ISSN 1040-0605. - 318:(2020), pp. L376-L385. [10.1152/ajplung.00311.2019]

Modeling pulmonary fibrosis through Bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation

Francesca Ravanetti;Luisa Ragionieri;Roberta Ciccimarra;Ferdinando Gazza;Antonio Cacchioli;
2020-01-01

Abstract

The systemic delivery of bleomycin (BLM) to mice through subcutaneously implanted osmotic minipumps may be used to experimentally mimic the typical features of systemic sclerosis and related interstitial lung diseases. The published studies on this model principally focused on induced dermal modifications, probably because lung lesions are typically mild, subpleurally localized and difficult to analyze. The use of high BLM doses to increase their severity has been proposed, but is ethically questionable because of compromising animal welfare. We propose a tailored histomorphometric method suitable to detect and quantify this type of mild lung lesions. Using a two steps automated image analysis, a peripheral region of interest with a depth of 250 µm from the pleural edge was defined on whole slide images and the fibrotic foci were histomorphometrically characterized. The effects of different BLM doses on lung alterations were evaluated in C57BL/6 mice and 60 U/kg resulted in a fair compromise between fibrotic lesions and animal welfare. This dose was also tested in time-course experiments. The analysis revealed a peak of histologic fibrotic-like alterations, cytokine expression, metalloprotease and macrophagic activation, between the 21th and 28th day post pump implant. The induced dermal fibrosis was characterized by the progressive loss of the white dermal adipose layer, an increase of dermal thickness, dermal hyperplasia and more compacted collagen fibers. Despite the trend to spontaneous resolution, our model allowed a double organ readout of the BLM effect and the identification of a therapeutic window for testing pharmacological compounds without using life threatening doses.
2020
Modeling pulmonary fibrosis through Bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation / Ravanetti, Francesca; Ragionieri, Luisa; Ciccimarra, Roberta; Ruscitti, Francesca; Pompilio, Daniela; Gazza, Ferdinando; Villetti, Gino; Cacchioli, Antonio; Stellari, Fabio F.. - In: AMERICAN JOURNAL OF PHYSIOLOGY. LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. - ISSN 1040-0605. - 318:(2020), pp. L376-L385. [10.1152/ajplung.00311.2019]
File in questo prodotto:
File Dimensione Formato  
Ravanetti et al 2020 ajplung.00311.2019.pdf

accesso aperto

Tipologia: Versione (PDF) editoriale
Licenza: Creative commons
Dimensione 3.97 MB
Formato Adobe PDF
3.97 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2868715
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 18
social impact